CR
Charles River Laboratories
CRL13F as of Jun 30, 2026 · next update ~Nov 14
Limited coverage
Only 2 funds we track own this stock, so quarterly sentiment and aggregates may be sparse.
Who's buying CRL
Top funds mostly added to Charles River Laboratories in Q2 (Apr–Jun)
Buying:
Funds2InsidersCongress
- Top funds2 of 2 bought more, 1 sold some. Largest: Harris Associates, $508.3M (1% of its portfolio).
- Insiders1 insider bought, 12 sales in 12 months. Plus 1 payroll-plan purchase, not counted.
- CongressNo trades disclosed in the last 12 months.
2 funds$849.9M held2.0% avg. weightQ2: 2 bought / 1 sold
13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).
Share price · market data, not from 13F reports
Q2 2026